GlassScriptPhysician profile
Zane Giffen
NPI 1841653029
$9,771.97
in general payments reported to CMS, 2019-2025
33 companies · $2,443 in 2025
The $2,443 reported for 2025 was more than what 84% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $99.20 · 2021: $497 · 2022: $2,932 · 2023: $2,930 · 2024: $872 · 2025: $2,443.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,930 · Travel and Lodging: $2,314.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,930.25 |
| Travel and Lodging | $2,313.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,286.81 | 2022-2025 | Lithovue, Rezum Generator, Axonics |
| Teleflex LLC | $1,648.68 | 2021-2025 | Urolift, Barrigel |
| Procept Biorobotics Corporation | $1,442.16 | 2025 | |
| Axonics, INC. | $954.10 | 2020-2024 | Axonics, Bulkamid |
| Sumitomo Pharma America, INC. | $630.04 | 2023-2025 | Gemtesa, Orgovyx |
| Medtronic, INC. | $383.52 | 2021-2025 | Interstim |
| Convatec INC. | $302.09 | 2022-2025 | |
| Endo Pharmaceuticals INC. | $279.72 | 2021-2023 | Xiaflex, Aveed |
| Urovant Sciences INC | $257.43 | 2021-2022 | |
| Astellas Pharma US INC | $222.76 | 2021-2024 | Veozah, Myrbetriq |
| Abbvie INC. | $185.42 | 2022-2025 | |
| Antares Pharma, INC. | $128.86 | 2022-2025 | Xyosted |
| C. R. Bard, INC. & Subsidiaries | $119.44 | 2024 | Bard Urinary Drainage Bag |
| Myovant Sciences INC. | $95.04 | 2021-2022 | |
| Progenics Pharmaceuticals, INC. | $92.09 | 2022-2024 | Pylarify |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Halozyme INC | $82.15 | 2023 | |
| Laborie Medical Technologies Corp. | $79.04 | 2025 | |
| Rochester Medical Corporation | $72.34 | 2021-2022 | |
| Olympus America INC. | $70.94 | 2025 | Itind System |
| Urogen Pharma, INC. | $61.61 | 2023-2025 | Jelmyto |
| Caldera Medical, INC | $55.65 | 2022 | |
| Dendreon Pharmaceuticals LLC | $50.86 | 2025 | Provenge |
| Janssen Biotech, INC. | $49.70 | 2025 | Erleada |
| Genzyme Corporation | $32.09 | 2023 | |
| Clarus Therapeutics INC. | $31.43 | 2021 | |
| Novartis Pharmaceuticals Corporation | $26.31 | 2025 | |
| Calyxo, INC. | $24.21 | 2025 | Cvac Aspiration System |
| Tolmar, INC. | $19.72 | 2025 | Jatenzo, Eligard |
| Verity Pharmaceuticals INC. | $19.63 | 2025 | Trelstar |
| Coloplast Corp | $18.94 | 2022 | |
| Photocure INC | $18.31 | 2024 | Cysview |
| Travere Therapeutics, INC. | $15.78 | 2021 | |
| Srs Medical Systems, INC. | $15.10 | 2025 | Ct3000 Pro Base Unit, Urocuff-Dc Disposable, Single |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zane Giffen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.